NCT00005081View on ClinicalTrials.gov

Carmustine Plus O6-benzylguanine in Treating Patients With Recurrent or Progressive Glioma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

August 31, 2000

Primary Completion Date

April 30, 2001

Study Completion Date

April 30, 2001

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG

O6-benzylguanine

DRUG

carmustine

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

collaborator

National Cancer Institute (NCI)

NIH

lead

Duke University

OTHER